{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:19:56Z","timestamp":1788142796187,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd015350","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000}}],"reference-count":108,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015350.pub2","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T10:36:47Z","timestamp":1753785407000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Topical antibiotics for treating bacterial keratitis: a network meta-analysis"],"prefix":"10.1002","volume":"2025","author":[{"given":"Anna","family":"Song","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; Norfolk and Norwich University Hospitals; Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Henein","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Biomedical Research Centre for Ophthalmology; Moorfields Eye Hospital and University College London Institute of Ophthalmology; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[{"name":"The London School of Hygiene & Tropical Medicine; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Denver Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren SJ","family":"Ting","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, College of Medicine and Health; University of Birmingham; Birmingham UK"},{"name":"Academic Ophthalmology; School of Medicine, University of Nottingham; Nottingham UK"},{"name":"Birmingham and Midland Eye Centre; Sandwell and West Birmingham NHS Trust; Birmingham UK"},{"name":"Ophthalmology & Visual Sciences Academic Clinical Programme; Duke-NUS Graduate Medical School; Singapore Singapore"},{"name":"Singapore National Eye Centre; Singapore Eye Research Institute; Singapore Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD015350.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41433-020-01339-3","article-title":"Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance","volume":"35","author":"Ting","year":"2021","journal-title":"Eye (London, England)"},{"issue":"10","key":"10.1002\/14651858.CD015350.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/bjophthalmol-2018-312881","article-title":"Queensland microbial keratitis database: 2005-2015","volume":"103","author":"Green","year":"2019","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015350.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/bjophthalmol-2020-316128","article-title":"12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study","volume":"105","author":"Ting","year":"2021","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015350.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","article-title":"The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance","volume":"64","author":"Ung","year":"2019","journal-title":"Survey of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD015350.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00417-020-04681-0","article-title":"Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation","volume":"258","author":"Khoo","year":"2020","journal-title":"Graefes Archives for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajo.2018.07.040","article-title":"The Asia cornea society infectious keratitis study: a prospective multicenter study of infectious keratitis in Asia","volume":"195","author":"Khor","year":"2018","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015350.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bjo.2009.169607","article-title":"Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature","volume":"95","author":"Shah","year":"2011","journal-title":"British Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD015350.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41433-020-01272-5","article-title":"Seasonal patterns of incidence, demographic factors and microbiological profiles of infectious keratitis: the Nottingham Infectious Keratitis Study","volume":"35","author":"Ting","year":"2021","journal-title":"Eye (London, England)"},{"issue":"5","key":"10.1002\/14651858.CD015350.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/ICL.0000000000000642","article-title":"The prevalence of bacteria, fungi, viruses, and acanthamoeba from 3,004 cases of keratitis, endophthalmitis, and conjunctivitis","volume":"46","author":"Kowalski","year":"2020","journal-title":"Eye & Contact Lens"},{"issue":"12","key":"10.1002\/14651858.CD015350.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/ICO.0000000000001390","article-title":"Bacterial keratitis in Toronto: a 16-year review of the microorganisms isolated and the resistance patterns observed","volume":"36","author":"Tam","year":"2017","journal-title":"Cornea"},{"issue":"8","key":"10.1002\/14651858.CD015350.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/eye.2017.55","article-title":"Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital","volume":"31","author":"Tan","year":"2017","journal-title":"Eye (London, England)"},{"issue":"10","key":"10.1002\/14651858.CD015350.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41433-019-0463-6","article-title":"An 11-year analysis of microbial keratitis in the South West of England using brain-heart infusion broth","volume":"33","author":"Tavassoli","year":"2019","journal-title":"Eye (London, England)"},{"issue":"8","key":"10.1002\/14651858.CD015350.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41433-018-0085-4","article-title":"A 10-year analysis of microbiological profiles of microbial keratitis: the North East England Study","volume":"32","author":"Ting","year":"2018","journal-title":"Eye (London, England)"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"715118","DOI":"10.3389\/fmed.2021.715118","article-title":"Risk factors, clinical outcomes, and prognostic factors of bacterial keratitis: the Nottingham Infectious Keratitis Study","volume":"8","author":"Ting","year":"2021","journal-title":"Frontiers in Medicine (Lausanne)"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0015|cit15","first-page":"224\u2013230","article-title":"Presumed microbial keratitis cases resulting in evisceration and enucleation in Sydney, Australia","volume":"31","author":"Cabrera-Aguas","year":"2021","journal-title":"Ocular Immunology and Inflammation"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1167\/iovs.09-3933","article-title":"Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis","volume":"51","author":"Kaye","year":"2010","journal-title":"Investigative Ophthalmology and Vision Science"},{"issue":"2","key":"10.1002\/14651858.CD015350.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/ICL.0000000000000517","article-title":"Polymicrobial keratitis with Cryptococcus curvatus, Candida parapsilosis, and Stenotrophomonas maltophilia after penetrating keratoplasty: a rare case report with literature review","volume":"45","author":"Ting","year":"2019","journal-title":"Eye & Contact Lens"},{"issue":"11","key":"10.1002\/14651858.CD015350.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/jof7110966","article-title":"Clinical characteristics and outcomes of fungal keratitis in the United Kingdom 2011-2020: a 10-year study","volume":"7","author":"Ting","year":"2021","journal-title":"Journal of Fungi"},{"issue":"7","key":"10.1002\/14651858.CD015350.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/ICL.0000000000000993","article-title":"Corneal culture and antibiotic susceptibility results for microbial keratitis in the Mid-Atlantic region of the United States, 2016-2020","volume":"49","author":"Shekhawat","year":"2023","journal-title":"Eye & Contact Lens"},{"issue":"5","key":"10.1002\/14651858.CD015350.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaophthalmol.2020.0155","article-title":"Trends in antibiotic resistance among ocular microorganisms in the United States from 2009 to 2018","volume":"138","author":"Asbell","year":"2020","journal-title":"JAMA Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD015350.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00417-023-06003-6","article-title":"Practice patterns in the management of bacterial keratitis: a five-continent survey","volume":"261","author":"Wespiser","year":"2023","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/bjophthalmol-2016-309870","article-title":"Emergency corneal grafting in the UK: a 6-year analysis of the UK Transplant Registry","volume":"102","author":"Hossain","year":"2018","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0023|cit23","unstructured":"Said DG Rallis KI Al-Aqaba MA Ting DSJ Dua HS Surgical management of infectious keratitis Ocular Surface 10.1016\/j.jtos.2021.09.005"},{"issue":"4","key":"10.1002\/14651858.CD015350.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jtos.2019.08.006","article-title":"Photoactivated chromophore for infectious keratitis - corneal cross-linking (PACK-CXL): a systematic review and meta-analysis","volume":"17","author":"Ting","year":"2019","journal-title":"Ocular Surface"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1038\/s41598-021-92366-x","article-title":"Amniotic membrane transplantation for infectious keratitis: a systematic review and meta-analysis","volume":"11","author":"Ting","year":"2021","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1002\/14651858.CD015350.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archophthalmol.2011.315","article-title":"Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT)","volume":"130","author":"Srinivasan","year":"2012","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD015350.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ajo.2012.06.001","article-title":"Nocardia keratitis: clinical course and effect of corticosteroids","volume":"154","author":"Lalitha","year":"2012","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD015350.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005430.pub3","article-title":"Topical corticosteroids as adjunctive therapy for bacterial keratitis","author":"Herretes","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD015350.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013001.pub2","article-title":"Corneal collagen cross-linking for bacterial infectious keratitis","author":"Davis","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e000047","DOI":"10.1136\/bmjophth-2016-000047","article-title":"Empirical treatment of bacterial keratitis: an international survey of corneal specialists","volume":"2","author":"Austin","year":"2017","journal-title":"BMJ Open Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD015350.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1136\/bjophthalmol-2013-304660","article-title":"Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials","volume":"98","author":"McDonald","year":"2014","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ajo.2016.10.004","article-title":"Prospective, randomized clinical trial of povidone-iodine 1.25% solution versus topical antibiotics for treatment of bacterial keratitis","volume":"176","author":"Isenberg","year":"2017","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ICO.0000000000000664","article-title":"Gatifloxacin 0.3% versus fortified tobramycin-cefazolin in treating nonperforated bacterial corneal ulcers: randomized, controlled trial","volume":"35","author":"Sharma","year":"2016","journal-title":"Cornea"},{"issue":"12. Art. No.: C","key":"10.1002\/14651858.CD015350.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015350","article-title":"Topical antibiotics for treating bacterial keratitis: a network meta-analysis","author":"Ting","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jclinepi.2016.11.015","article-title":"Additional considerations are required when preparing a protocol for a systematic review with multiple interventions","volume":"83","author":"Chaimani","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD015350.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis too","volume":"3","author":"Salanti","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0038|cit38","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0039|cit39","unstructured":"Retraction Watch Database https:\/\/retractiondatabase.org\/RetractionSearch.aspx"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0040|cit40","unstructured":"PICO Portal PICO Portal 2023"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0041|cit41","unstructured":"Overview: Systematic Review Data Repository Plus (SRDR+) Effective Health Care Program Agency for Healthcare Research and Quality 2022"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0042|cit42","unstructured":"Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0043|cit43","unstructured":"Stata Statistical Software StataCorp LLC 2017"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0044|cit44","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13643-017-0473-z","article-title":"Approaches to interpreting and choosing the best treatments in network meta-analyses","volume":"6","author":"Mbuagbaw","year":"2017","journal-title":"Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD015350.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0047|cit47","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0048|cit48","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"issue":"7-8","key":"10.1002\/14651858.CD015350.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","article-title":"Network meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0051|cit51","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2\/"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0052|cit52","first-page":"I4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD015350.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0054|cit54","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0055|cit55","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"issue":"11","key":"10.1002\/14651858.CD015350.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD015350.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD015350.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0060|cit60","first-page":"e1080","article-title":"CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Systematic Reviews"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0061|cit61","unstructured":"Chaimani A Caldwell DM Li T Higgins JP Salanti G Chapter 11: Undertaking network meta-analyses [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/jclinepi.2019.04.018","article-title":"Development of the grading of recommendations assessment, development and evaluation (GRADE) summary of findings (SoF) table for network meta-analysis","volume":"115","author":"Yepes-Nu\u00f1ez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12916-021-02166-3","article-title":"ROB-MEN: A tool to assess risk of bias due to missing evidence in network meta-analysis","volume":"19","author":"Chioccia","year":"2021","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Nichols K Liu CC Jensen H Davitt W Trocme S Vajpayee R Safety and efficacy of 0.3% gatifloxacin as compared with 0.3% ciprofloxacin for the treatment of acute bacterial corneal ulcers Investigative Ophthalmology & Visual Science 2006 77 295","DOI":"10.1016\/j.optm.2006.04.077"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0065|cit65","unstructured":"Prajna V Vajpayee R Trocme S Davitt WF Jensen H Liu R Safety and efficacy of gatifloxacin 0.3% as compared with ciprofloxacin 0.3% for the treatment of acute bacterial corneal ulcers Investigative Ophthalmology & Visual Science 2006 47 1916"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0066|cit66","unstructured":"Safety and efficacy study of gatifloxacin compared with ciprofloxacin in patients with acute bacterial corneal ulcers clinicaltrials.gov\/study\/NCT00651586"},{"issue":"9","key":"10.1002\/14651858.CD015350.pub2-BIB0067|cit67","first-page":"3659","article-title":"Besifloxacin ophthalmic suspension in patients with bacterial keratitis: a prospective, randomized clinical study","volume":"59","author":"Zaguia","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0068|cit68","unstructured":"Besifloxacin in bacterial keratitis clinicaltrials.gov\/study\/NCT02497365"},{"issue":"3","key":"10.1002\/14651858.CD015350.pub2-BIB0069|cit69","first-page":"246","article-title":"Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers","volume":"87","author":"Booranapong","year":"2004","journal-title":"Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]"},{"issue":"9","key":"10.1002\/14651858.CD015350.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","article-title":"Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial","volume":"114","author":"Constantinou","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Rapuano CJ Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial Evidence-Based Ophthalmology 2008 9 1 26 7 10.1097\/IEB.0b013e31815f0cd8","DOI":"10.1097\/IEB.0b013e31815f0cd8"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0072|cit72","unstructured":"Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomised clinical trial anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12606000406505"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ajo.2016.10.004","article-title":"Prospective, randomized clinical trial of povidone-iodine 1.25% solution versus topical antibiotics for treatment of bacterial keratitis","volume":"176","author":"Isenberg","year":"2017","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0074|cit74","unstructured":"A clinical trial of povidone-iodine for the treatment of bacterial corneal ulcers clinicaltrials.gov\/study\/NCT00386958"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0075|cit75","first-page":"S83","article-title":"Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis","volume":"87","author":"Erjongmanee","year":"2004","journal-title":"Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5372\/1905-7415.0501.009","article-title":"The efficacy and safety of 0.5% Levofloxacin versus fortified Cefazolin and Amikacin ophthalmic solution for the treatment of suspected and culture-proven cases of infectious bacterial keratitis: a comparative study","volume":"5","author":"Kasetsuwan","year":"2011","journal-title":"Asian Biomedicine"},{"issue":"7","key":"10.1002\/14651858.CD015350.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/ICO.0b013e3181ca2ba3","article-title":"Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers","volume":"29","author":"Shah","year":"2010","journal-title":"Cornea"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0078|cit78","first-page":"19","article-title":"Cefazolin-gentamicin versus vancomycin-ceftazidime eye drops for bacterial corneal ulcers; a randomized clinical trial","volume":"4","author":"Dehghani","year":"2009","journal-title":"Journal of Ophthalmic & Vision Research"},{"issue":"11","key":"10.1002\/14651858.CD015350.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0161-6420(96)30416-8","article-title":"Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin\/cefazolin in patients with bacterial corneal ulcers","volume":"103","author":"Hyndiuk","year":"1994","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD015350.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2298\/VSP160510284J","article-title":"The efficacy of moxifloxacin in patients with bacterial keratitis","volume":"75","author":"Janicijevic","year":"2018","journal-title":"Vojnosanitetski Pregled"},{"issue":"3","key":"10.1002\/14651858.CD015350.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.22159\/ijpps.2024v16i3.49807","article-title":"A comparative study to evaluate efficacy and safety of topical ciprofloxacin vs fortified gentamicin-ceftazidime in bacterial keratitis at a tertiary care center in Telangana","volume":"16","author":"Karunasree","year":"2024","journal-title":"International Journal of Pharmacy and Pharmaceutical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/bjo.2004.044412","article-title":"A randomised trial of povidone-iodine to reduce visual impairment from corneal ulcers in rural Nepal","volume":"88","author":"Katz","year":"2004","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0083|cit83","first-page":"1883","article-title":"Comparative clinical study of 0.5% cefmenoxime (CMX) ophthalmic solution with 1% sulbenicillin (SBPC) ophthalmic solution used as control","volume":"36","author":"Manabe","year":"1985","journal-title":"Folia Ophthalmologica Japonica"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/archopht.1995.01100100045026","article-title":"Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group","volume":"113","author":"O'Brien","year":"1995","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0085|cit85","first-page":"3948","article-title":"Comparative clinical efficacy of topical ofloxacin vs. combined fortified cefazolin plus tobramycin in therapy of acute bacterial keratitis","volume":"36","author":"O'Brien","year":"1995","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD015350.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archopht.1996.01100130624031","article-title":"Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis","volume":"114","author":"Baker","year":"1996","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD015350.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajo.2005.08.081","article-title":"Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis","volume":"141","author":"Parmar","year":"2006","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD015350.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00003226-200103000-00013","article-title":"Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis","volume":"20","author":"Prajna","year":"2001","journal-title":"Cornea"},{"issue":"5","key":"10.1002\/14651858.CD015350.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/01.ico.0000214220.67872.b1","article-title":"Clinical trial of povidone-iodine (Betadine) versus placebo in the pretreatment of corneal ulcers","volume":"25","author":"Gregori","year":"2006","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD015350.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s150100050068","article-title":"Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis","volume":"28","author":"Khokhar","year":"2000","journal-title":"Infection"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/eye.1999.220","article-title":"Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis","volume":"13","author":"Panda","year":"1999","journal-title":"Eye (London, England)"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0092|cit92","unstructured":"Study for the safety and efficacy of hypochlorite eye drops in the treatment of infectious keratitis www.chictr.org.cn\/showprojEN.html?proj=37416"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0093|cit93","unstructured":"Understanding the role of 1.5% levofloxacin drops in eyes with bacterial keratitis https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2020\/06\/025981"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0094|cit94","unstructured":"Mirzaeei S Investigating the efficacy of insert nanofibers containing vancomycin and amikacin in patients with infectious keratitis trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20130812014333N216"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0095|cit95","unstructured":"Jadid K Safety evaluation of eye drops containing antibacterial peptides in the treatment of infectious bacterial keratitis trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20181229042160N4"},{"issue":"7","key":"10.1002\/14651858.CD015350.pub2-BIB0096|cit96","first-page":"776","article-title":"Topical ciprofloxacin for bacterial corneal ulcer","volume":"83","author":"Kosrirukvongs","year":"2000","journal-title":"Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]"},{"issue":"3","key":"10.1002\/14651858.CD015350.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2174\/1570163817666200214113055","article-title":"Efficacy of honey-based ophthalmic formulation in patients with corneal ulcer: a randomized clinical trial","volume":"18","author":"Nejabat","year":"2021","journal-title":"Current Drug Discovery Technologies"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0098|cit98","unstructured":"Clinical trial of comparison the effect of honey drop and ciprofloxacin drop in corneal ulcer trialsearch.who.int\/Trial2.aspx?TrialID=IRCT2015020120892N1"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0099|cit99","first-page":"1902","article-title":"Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy","volume":"104","author":"The Ofloxacin Study Group","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0100|cit100","unstructured":"Pavesio C Morlet N Minassian D Allen B Tullo A Dart J Ofloxacin monotherapy for the primary treatment of microbial keratitis Ophthalmology 1996 37 4743"},{"issue":"6","key":"10.1002\/14651858.CD015350.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.ophtha.2012.11.013","article-title":"Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial","volume":"120","author":"Sharma","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0102|cit102","unstructured":"Evaluation of efficacy of moxifloxacin (0.5%) in the treatment of non-perforated bacterial corneal ulcers trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN10323655"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0103|cit103","first-page":"664","article-title":"Chlorhexidine gluconate 0.02% as adjunct to primary treatment for corneal bacterial ulcers","volume":"11","author":"Geffen","year":"2009","journal-title":"Israel Medical Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/ICO.0000000000000664","article-title":"Gatifloxacin 0.3% versus fortified tobramycin-cefazolin in treating nonperforated bacterial corneal ulcers: randomized, controlled trial","volume":"35","author":"Sharma","year":"2016","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD015350.pub2-BIB0105|cit105","unstructured":"Evaluation of Gatifloxacin in treatment of bacterial corneal ulcers trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2015\/05\/005781"},{"issue":"4","key":"10.1002\/14651858.CD015350.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4103\/0301-4738.53051","article-title":"Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade","volume":"57","author":"Gopinathan","year":"2009","journal-title":"Indian Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD015350.pub2-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005083.pub4","article-title":"Honey as a topical treatment for wounds","author":"Jull","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD015350.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/ICL.0000000000000059","article-title":"Community practice patterns for bacterial corneal ulcer evaluation and treatment","volume":"41","author":"Park","year":"2015","journal-title":"Eye & Contact Lens"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:05:18Z","timestamp":1788141918000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015350.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":108,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015350.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]}}}